Intelgenx Financial Statements From 2010 to 2026
| IGXTDelisted Stock | USD 0.17 0.00 0.00% |
Check Intelgenx Technologs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelgenx Technologs' main balance sheet or income statement drivers, such as , as well as many indicators such as . Intelgenx financial statements analysis is a perfect complement when working with Intelgenx Technologs Valuation or Volatility modules.
Intelgenx |
Intelgenx Technologs Company Operating Margin Analysis
Intelgenx Technologs' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Intelgenx Technologs Operating Margin | (7.39) % |
Most of Intelgenx Technologs' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intelgenx Technologs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Intelgenx Technologs has an Operating Margin of -7.3895%. This is 78.94% lower than that of the Pharmaceuticals sector and 93.41% lower than that of the Health Care industry. The operating margin for all United States stocks is 34.11% higher than that of the company.
Intelgenx Technologs Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Intelgenx Technologs's current stock value. Our valuation model uses many indicators to compare Intelgenx Technologs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intelgenx Technologs competition to find correlations between indicators driving Intelgenx Technologs's intrinsic value. More Info.Intelgenx Technologs is rated fourth overall in return on equity category among its peers. It also is rated fourth overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Intelgenx Technologs' earnings, one of the primary drivers of an investment's value.About Intelgenx Technologs Financial Statements
Intelgenx Technologs shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Intelgenx Technologs investors may analyze each financial statement separately, they are all interrelated. The changes in Intelgenx Technologs' assets and liabilities, for example, are also reflected in the revenues and expenses on on Intelgenx Technologs' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada. Intelgenx Technologs operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Intelgenx Pink Sheet
If you are still planning to invest in Intelgenx Technologs check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intelgenx Technologs' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |